We have recently described (1-3) a non-neoplastic lymphoproliferative disease in C57BL/6 mice infected as adults with the LP-BM5 murine leukemia virus (MuLV) mixture originally isolated by Laterjet and Duplan (4). This disease has many of the features of the acquired immunodeficiency syndrome (AIDS), including polyclonal B lymphocyte activation, hypergammaglobulinemia, lymphadenopathy, and profound immunodeficiency (1-6). The retroviral origin of the murine disease and the striking similarities in immunologic abnormalities to AIDS lead us to use the abbreviations MAIDS (murine acquired immunodeficiency syndrome) for the LP-BM5 MuLV-induced immunodeficiency disease . In man, the human immunodeficiency viruses (HIV) are thought to cause immunologic abnormalities by depleting CD4' helper T cells (7, 8) and by directly activating B cells (9) . In mice, LP-BM5 MuLV infection is known to decrease helper T cell function (1), but it is unclear whether alterations in T cell function are related to the observed B cell hyperactivity. Since polyclonal activation of B cells normally precedes loss of helper T cell function in both AIDS and MAIDS, and because normal B cell activation is dependent upon a series ofT cell-derived lymphokines (10-13), it is possible that the initial effects of retroviral infection include a polyclonal activation of helper T cells that in turn act to stimulate B cells. We have examined these issues by studying the course of MAIDS in T celldeficient athymic C57BL/10 nu/nu mice.
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. -r-~- showed no histopathologic evidence of MAIDS .
injected intravenously into C57BL/10 nu/nu recipients . The splenic T cells were >95% ThyA + by flow cytometric analysis . All such T cell-reconstituted nu/nu mice showed evidence of T cell function (see Fig. 3 ) . Virus Assays. Mitomycin C-treated suspensions of spleen or lymph node cells were tested in infectious center assays as described (14) . Briefly, expression of infectious ecotropic MuLV was quantitated by the XC plaque assay of SC-1 cells cocultured with lymphocytes . Expression of infectious MCF MuLV was quantitated by detection of infectious centers in mink lung cells using fluorescein-labeled anti-MuLV antibodies . Values are expressed as log o FFU per 107 cells .
Assays of Immunologic Function . Serum IgM levels were determined by an ELISA technique using goat anti-mouse IgM-coated microtiter plate wells. IgM binding was detected with a peroxidase-labeled goat anti-mouse Ig antibody . B cell proliferation was stimulated with lipopolysaccharide from E. coli 0111 : B4 or with affinity-purified goat antiIgM antibodies .
[sH]Thymidine incorporation was determined after a 4-h pulse on the third day of culture . In vitro antibody responses to the T cell-independent antigens trinitrophenyl (TNP)-lipopolysaccharide, TNP-B . abortus, and TNP-Ficoll were determined by the plaque-forming cell assay using TNP-sheep erythrocyte targets as described (15) .
Results
Adult C57BL/10 nu/nu mice or their nu/+ or +/+ littermates (hereafter nu/+) were infected with LP-BM5 MuLV by intraperitoneal injection (10) . The mice were observed for lymph node enlargement, elevation of serum immunoglobulin levels, and death . cell-independent antigens (12) were equivalent in virus-infected and uninfected nu/nu mice examined at 4, 8, 12, and 16 wk after infection (data not shown) . The major features of MAIDS thus were absent in virus-infected nu/nu mice.
One potential explanation for the resistance of nu/nu mice to virus-induced immunodeficiency disease could be a reduced replication of either the ecotropic or MCF components of LP-BM5 MuLV in nu/nu mice. To evaluate this possibility, spleen and lymph node cells from C57BL/10 nu/nu and +/+ mice were examined in infectious center assays (13) at various times after inoculation of LP-BM5 MuLV for the expression of ecotropic and MCF viruses (Fig. 2) . At each time, equivalent levels of ecotropic or MCF virus-producing cells were detected in lymphoid tissues of mice of either genotype. These results indicate that LP-BM5 MuLV have no direct effect on the function of B lymphocytes and, further, that T cells exert little or no control over virus replication .
Since the nu/nu mutation involves phenotypic manifestations other than the simple deletion of T lymphocytes (16, 17) , the conclusion that T cells are required for the expression of LP-BM5 MuLV-induced immunodeficiency disease depends upon the demonstration that T cells are sufficient to reconstitute disease susceptibility of nu/nu mice . Accordingly, groups of nu/nu mice were injected intravenously with mature splenic T lymphocytes (15), and 2 wk later were infected with LP-BM5 MuLV . The immunologic status of the mice was determined 3 and 6 wk after infection. The T cell reconstitution of nu/nu mice restored T lymphocyte function, and LP-BM5 MuLV infection of such T cellrestored mice resulted in clear signs of immunodeficiency disease (Fig. 3) . IgM levels were elevated, proliferative responses to mitogens were depressed, and antibody responses to specific antigens were absent in the T cell-reconstituted, LP-BM5 MuLV-infected group of mice . The in vivo antibody response to TNPFicoll, a T-independent antigen, was normal in all groups of nu/nu mice except the T cell-reconstituted, virus-infected group (data not shown) . These data confirm the T cell dependency of MAIDS. (11) (12) (13) , e.g., IL-2, IL-4 (BSF-1), and BCGF-II, and it is likely that the polyclonal B cell activation that heralds the onset of MAIDS cannot proceed without such T cell-derived lymphokines. The suggestion that virus-induced B cell abnormalities in MAIDS are T cell-dependent differs from the conclusion that B cell dysfunction in AIDS reflects a direct effect of HIV on B cells (9) . Many differences between MAIDS and AIDS, including the etiologic retroviruses and the infected species could explain this apparent discrepancy, but the observation that mice selectively depleted of L3T4' helper T cells do not develop MAIDS (Yetter and Morse, unpublished observations) confirms the required role of T cells in the murine disease . MAIDS therefore appears to result from a virally induced distortion of the normal pathways for B cell activation . These observations raise the question of whether there is an early stage in the progression of AIDS for which intact helper T cell function is required .
Summary
Athymic nu/nu mice were found to be resistant to the immunodeficiency disease and lethality induced in normal mice by the injection of the LP-BM5 mixture of murine retroviruses (LP-BM5 MuLV) . Susceptibility to disease induction was reconstituted by injection of nu/nu mice with purified, mature T lymphocytes. The extent of viral replication of both the ecotropic and mink cell focus forming (MCF) components of LP-BM5 MuLV was equivalent in both nu/ nu and normal animals . Retrovirally-induced immunodeficiency disease in mice (MAIDS) is thus dependent upon the presence of functional T lymphocytes, and high virus titers in athymic mice have little or no effect on the immune system .
